Goldman Sachs Reiterates Neutral Rating on Bristol-Myers Squibb Co. (BMY)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 61.55 -0.06 (0.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.61 | 52 Week High | $77.12 | |||
| Open | $61.21 | 52 Week Low | $49.03 | |||
| Day High | $61.64 | P/E | 39.97 | |||
| Day Low | $60.92 | EPS | $1.54 | |||
| Volume | 7,778,058 | |||||
